Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-12-014852)

Filing Details

Accession Number:: 0001127602-12-014852
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-04-27 20:18:02
Reporting Period:: 2012-04-26

Filing Date:: 2012-04-27
Accepted Time:: 2012-04-27 20:18:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
850693	Allergan Inc	AGN	Pharmaceutical Preparations (2834)	951622442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1298861	M Trevor Jones	2525 Dupont Drive Irvine CA 92612		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-04-26	1,500	$95.13	21,460	No	4	S	Direct
Common Stock	Acquisiton	2012-04-26	1,000	$36.49	22,460	No	4	M	Direct
Common Stock	Disposition	2012-04-26	1,000	$95.13	21,460	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Nonemployee Director Stock Option (Right to Buy)	Disposition	2012-04-26	1,000	$0.00	1,000	$36.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,000	2006-04-26	2015-04-26	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 10, 2012.
The per share exercise price is the closing price of Allergan common stock as of April 25, 2005, rounded upwards to three decimals.
Option is fully vested and exercisable on the one year (1) year anniversary of its grant.